Reviewing MorphoSys AG (MOR)’s and INSYS Therapeutics Inc. (NASDAQ:INSY)’s results

MorphoSys AG (NASDAQ:MOR) and INSYS Therapeutics Inc. (NASDAQ:INSY), both competing one another are Biotechnology companies. We will compare their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation.

Valuation Earnings

In table 1 we can see MorphoSys AG and INSYS Therapeutics Inc.’s top-line revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 shows us the return on assets, net margins and return on equity of both businesses.

Analyst Recommendations

Ratings and Recommendations for MorphoSys AG and INSYS Therapeutics Inc. can be find in next table.

On the other hand, INSYS Therapeutics Inc.’s potential upside is 87.20% and its consensus target price is $7.75.

Institutional Insider Ownership

The shares of both MorphoSys AG and INSYS Therapeutics Inc. are owned by institutional investors at 7.3% and 18.9% respectively. Insiders Comparatively, held 63.83% of INSYS Therapeutics Inc. shares.

Performance

In this table

... read more at: https://standardrecorder.com/2019/03/16/reviewing-morphosys-ag-mors-and-insys-therapeutics-inc-nasdaqinsys-results/

by